Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-2-28
pubmed:abstractText
Akt is a serine/threonine kinase that leads to stimulation of cell cycle progression, cell proliferation, and inhibition of apoptosis. To investigate the role of Akt in melanoma pathogenesis, we examined the expression of phospho-Akt (p-Akt; Ser-473) in melanocytic lesions at different stages and analyzed the correlations between the p-Akt expression level and clinicopathologic factors and patient survival.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1473-82
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15735123-Disease Progression, pubmed-meshheading:15735123-Disease-Free Survival, pubmed-meshheading:15735123-Dysplastic Nevus Syndrome, pubmed-meshheading:15735123-Female, pubmed-meshheading:15735123-Humans, pubmed-meshheading:15735123-Male, pubmed-meshheading:15735123-Melanoma, pubmed-meshheading:15735123-Middle Aged, pubmed-meshheading:15735123-Neoplasm Invasiveness, pubmed-meshheading:15735123-Neoplasm Metastasis, pubmed-meshheading:15735123-Nevus, pubmed-meshheading:15735123-Prognosis, pubmed-meshheading:15735123-Protein-Serine-Threonine Kinases, pubmed-meshheading:15735123-Proto-Oncogene Proteins, pubmed-meshheading:15735123-Proto-Oncogene Proteins c-akt, pubmed-meshheading:15735123-Skin Neoplasms, pubmed-meshheading:15735123-Survival Rate, pubmed-meshheading:15735123-Tumor Markers, Biological
pubmed:year
2005
pubmed:articleTitle
Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
pubmed:affiliation
Department of Medicine, Division of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't